Skip NavigationSkip to Content

Phototruncation cell tracking with near-infrared photoimmunotherapy using heptamethine cyanine dye to visualise migratory dynamics of immune cells

  1. Author:
    Fukushima, Hiroshi
    Furusawa, Aki
    Takao, Seiichiro
    Matikonda, Siddharth S
    Kano, Makoto
    Okuyama, Shuhei
    Yamamoto, Hiroshi
    Choyke, Peter L
    Schnermann,Martin
    Kobayashi, Hisataka
  2. Author Address

    Molecular Imaging Branch, Centre for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, 20892, USA., Chemical Biology Laboratory, Centre for Cancer Research, National Cancer Institute, NIH, Frederick, MD, 21702, USA., Molecular Imaging Branch, Centre for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, 20892, USA. Electronic address: kobayash@mail.nih.gov.,
    1. Year: 2024
    2. Date: Mar 14
    3. Epub Date: 2024 03 14
  1. Journal: EBioMedicine
    1. 102
    2. Pages: 105050
  2. Type of Article: Article
  3. Article Number: 105050
  1. Abstract:

    Noninvasive in vivo cell tracking is valuable in understanding the mechanisms that enhance anti-cancer immunity. We have recently developed a new method called phototruncation-assisted cell tracking (PACT), that uses photoconvertible cell tracking technology to detect in vivo cell migration. This method has the advantages of not requiring genetic engineering of cells and employing tissue-penetrant near-infrared light. We applied PACT to monitor the migration of immune cells between a tumour and its tumour-draining lymph node (TDLN) after near-infrared photoimmunotherapy (NIR-PIT). PACT showed a significant increase in the migration of dendritic cells (DCs) and macrophages from the tumour to the TDLN immediately after NIR-PIT. This migration by NIR-PIT was abrogated by inhibiting the sphingosine-1-phosphate pathway or Gai signaling. These results were corroborated by intranodal immune cell profiles at two days post-treatment; NIR-PIT significantly induced DC maturation and increased and activated the CD8+ T cell population in the TDLN. Furthermore, PACT revealed that NIR-PIT significantly enhanced the migration of CD8+ T cells from the TDLN to the tumour four days post-treatment, which was consistent with the immunohistochemical assessment of tumour-infiltrating lymphocytes and tumour regression. Immune cells dramatically migrated between the tumour and TDLN following NIR-PIT, indicating its potential as an immune-stimulating therapy. Also, PACT is potentially applicable to a wide range of immunological research. This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Centre for Cancer Research (grant number: ZIA BC011513 and ZIA BC011506). Published by Elsevier B.V.

    See More

External Sources

  1. DOI: 10.1016/j.ebiom.2024.105050
  2. PMID: 38490105
  3. PII : S2352-3964(24)00085-9

Library Notes

  1. Fiscal Year: FY2023-2024
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel